My Quote Request
6505-01-456-2066
20 Products
NDC00395-1237-91
IPECAC SYRUP,USP
NSN, MFG P/N
6505014562066
NSN
6505-01-456-2066
MFG
HUMCO INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IPECAC SYRUP USP 7% 30ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 7%, 30 ML BOTTLES; 12 PER PACKAGE
Related Searches:
NDC00069-3120-19
AZITHROMYCIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505014554559
NSN
6505-01-455-4559
NDC00069-3120-19
AZITHROMYCIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505014554559
NSN
6505-01-455-4559
MFG
PFIZER LABORATORIES DIV OF PFIZER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AZITHROMYCIN FOR ORAL SUSPENSION 200MG/5ML 15ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MICROGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200 MG/5 ML; 15 ML; POWDER; BOTTLE
Related Searches:
ZITHROMAX
AZITHROMYCIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505014554559
NSN
6505-01-455-4559
ZITHROMAX
AZITHROMYCIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505014554559
NSN
6505-01-455-4559
MFG
PFIZER LABORATORIES DIV OF PFIZER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AZITHROMYCIN FOR ORAL SUSPENSION 200MG/5ML 15ML BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MICROGRAMS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 200 MG/5 ML; 15 ML; POWDER; BOTTLE
Related Searches:
0338-0550-02
HEPARIN SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505014555193
NSN
6505-01-455-5193
0338-0550-02
HEPARIN SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505014555193
NSN
6505-01-455-5193
MFG
BAXTER GOVERNMENT CUSTOMER SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAFLEX CONTAINER; 24 UNITS PER CASE
Related Searches:
2B0802
HEPARIN SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505014555193
NSN
6505-01-455-5193
2B0802
HEPARIN SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505014555193
NSN
6505-01-455-5193
MFG
BAXTER GOVERNMENT CUSTOMER SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAFLEX CONTAINER; 24 UNITS PER CASE
Related Searches:
NDC0338-0550-02
HEPARIN SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505014555193
NSN
6505-01-455-5193
NDC0338-0550-02
HEPARIN SODIUM IN DEXTROSE INJECTION
NSN, MFG P/N
6505014555193
NSN
6505-01-455-5193
MFG
BAXTER GOVERNMENT CUSTOMER SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN SODIUM ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAFLEX CONTAINER; 24 UNITS PER CASE
Related Searches:
0338-0705-41
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP
NSN, MFG P/N
6505014555258
NSN
6505-01-455-5258
0338-0705-41
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP
NSN, MFG P/N
6505014555258
NSN
6505-01-455-5258
MFG
BAXTER GOVERNMENT CUSTOMER SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: HIGHLY CONCENTRATED POTASSIUM CHLORIDE IN WATER FOR INJECTION; VIAFLEX CONTAINER; 24 UNITS PER CASE
Related Searches:
2B0821
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP
NSN, MFG P/N
6505014555258
NSN
6505-01-455-5258
2B0821
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP
NSN, MFG P/N
6505014555258
NSN
6505-01-455-5258
MFG
BAXTER GOVERNMENT CUSTOMER SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: HIGHLY CONCENTRATED POTASSIUM CHLORIDE IN WATER FOR INJECTION; VIAFLEX CONTAINER; 24 UNITS PER CASE
Related Searches:
NDC0338-0705-41
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP
NSN, MFG P/N
6505014555258
NSN
6505-01-455-5258
NDC0338-0705-41
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE,USP
NSN, MFG P/N
6505014555258
NSN
6505-01-455-5258
MFG
BAXTER GOVERNMENT CUSTOMER SERVICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE PER LITER
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: HIGHLY CONCENTRATED POTASSIUM CHLORIDE IN WATER FOR INJECTION; VIAFLEX CONTAINER; 24 UNITS PER CASE
Related Searches:
8516000
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505014555535
NSN
6505-01-455-5535
8516000
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505014555535
NSN
6505-01-455-5535
MFG
C. R. BARD INC.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP SOLUTION A 40ML 20S
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SOLUTION A; 40 ML; 20'S; FOR USE W/ORTHOPEDIC AUTOTRANSFUSION SYSTEM
Related Searches:
98-0223
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505014555535
NSN
6505-01-455-5535
98-0223
ANTICOAGULANT CITRATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505014555535
NSN
6505-01-455-5535
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP SOLUTION A 40ML 20S
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SOLUTION A; 40 ML; 20'S; FOR USE W/ORTHOPEDIC AUTOTRANSFUSION SYSTEM
Related Searches:
NDC00536-7620-94
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505014555537
NSN
6505-01-455-5537
NDC00536-7620-94
SALICYLIC ACID COLLODION,MODIFIED
NSN, MFG P/N
6505014555537
NSN
6505-01-455-5537
MFG
WATSON PHARMA INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALICYLIC ACID COLLODION MODIFIED 13-15ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 13.000 MILLILITERS OR 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 17% IN A FLEXIBLE COLLODION OR COLLODION-LIKE VEHICLE; 13-15 ML; BOTTLE
Related Searches:
98-0382
LUBRICANT,SURGICAL
NSN, MFG P/N
6505014557944
NSN
6505-01-455-7944
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL 4OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 4 OZ; 12'S
Related Searches:
NDC00168-0205-36
LUBRICANT,SURGICAL
NSN, MFG P/N
6505014557944
NSN
6505-01-455-7944
MFG
NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL 4OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 4 OZ; 12'S
Related Searches:
SURGILUBE
LUBRICANT,SURGICAL
NSN, MFG P/N
6505014557944
NSN
6505-01-455-7944
MFG
NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL 4OZ BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: 4 OZ; 12'S
Related Searches:
98-0381
VERAPAMIL HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505014558428
NSN
6505-01-455-8428
98-0381
VERAPAMIL HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505014558428
NSN
6505-01-455-8428
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG/ML 2ML VIAL 5S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL OR VIAL
SPECIAL FEATURES: 2.5 MG/ML; 2 ML; AMPULE OR VIAL; 5'S
Related Searches:
NDC00409-4011-01
VERAPAMIL HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505014558428
NSN
6505-01-455-8428
NDC00409-4011-01
VERAPAMIL HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505014558428
NSN
6505-01-455-8428
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VERAPAMIL HYDROCHLORIDE INJECTION USP 2.5MG/ML 2ML VIAL 5S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL OR VIAL
SPECIAL FEATURES: 2.5 MG/ML; 2 ML; AMPULE OR VIAL; 5'S
Related Searches:
NDC00004-1964-02
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505014559983
NSN
6505-01-455-9983
NDC00004-1964-02
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505014559983
NSN
6505-01-455-9983
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP POWDER FORM 1GM P-B BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PIGGYBACK
Related Searches:
ROCEPHIN
CEFTRIAXONE SODIUM,USP
NSN, MFG P/N
6505014559983
NSN
6505-01-455-9983
MFG
ROCHE LABORATORIES INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTRIAXONE EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTRIAXONE SODIUM STERILE USP POWDER FORM 1GM P-B BT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: PIGGYBACK
Related Searches:
98-0482
IPECAC SYRUP,USP
NSN, MFG P/N
6505014562066
NSN
6505-01-456-2066
MFG
DEFENSE MEDICAL STANDARDIZATION BOARD
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IPECAC SYRUP USP 7% 30ML BT 12S
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 7%, 30 ML BOTTLES; 12 PER PACKAGE